Compass Therapeutics, Inc. Stock Forecast
Green day on Monday for Compass Therapeutics, Inc. stock after gaining 0.690%
(Updated on Apr 29, 2024)
The Compass Therapeutics, Inc. stock price gained 0.690% on the last trading day (Monday, 29th Apr 2024), rising from $1.45 to $1.46. During the last trading day the stock fluctuated 6.25% from a day low at $1.40 to a day high of $1.49. The price has fallen in 6 of the last 10 days and is down by -7.59% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 80 thousand shares were bought and sold for approximately $117.31 thousand.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.30 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.55% during the next 3 months and, with a 90% probability hold a price between $1.35 and $2.45 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CMPX Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Compass Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Compass Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.48 and $1.80. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -36.24%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Compass Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.36 and $1.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Compass Therapeutics, Inc. finds support just below today's level at $1.36. If this is broken, then the next support from accumulated volume will be at $1.25 and $1.20.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0875 between high and low, or 6.25%. For the last week, the stock has had daily average volatility of 8.24%.
Compass Therapeutics, Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CMPX) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Compass Therapeutics, Inc. to open at $1.45, and during the day (based on 14 day Average True Range), to move between $1.30 and $1.62, which gives a possible trading interval of +/-$0.156 (+/-10.72%) up or down from last closing price. If Compass Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.43% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.36 (6.85%) than the resistance at $1.57 (7.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Compass Therapeutics, Inc. will release earnings BMO on Thursday, May 02, 2024. We will update the financials statements for Compass Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.30% in the first trading day after earnings release.
Is Compass Therapeutics, Inc. stock A Buy?
The Compass Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Compass Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -3.506 Sell Candidate Unchanged
Predicted Opening Price for Compass Therapeutics, Inc. of Tuesday, April 30, 2024
| Fair opening price April 30, 2024 | Current price |
|---|---|
| $1.45 ( 0.742%) | $1.46 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CMPX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.54 | 5.25 % | |
| R2 | 1.50 | 2.96 % | ||
| R1 | 1.48 | 1.55 % | ||
| Current price: | 1.46 | |||
| Support | S1 | 1.42 | -3.03 % | |
| S2 | 1.40 | -4.45 % | ||
| S3 | 1.36 | -6.74 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.70 | 16.44 % | |
| R2 | 1.60 | 9.59 % | ||
| R1 | 1.57 | 7.53 % | ||
| Current price | 1.46 | |||
| Support | S1 | 1.36 | -6.85% | |
| S2 | 1.25 | -14.38% | ||
| S3 | 1.20 | -17.81% |
FAQ
Click here for our free guide on how to buy Compass Therapeutics, Inc. Stock.
